Home › Research › Long-term cohort studies
Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study
Jun Yu, Yuzhou Zhang, Mary T. Ho, Ka Wai Kam, Shi Song Rong, Alvin Lerrmann Young, Chi Pui Pang, Clement Chee Yung Tham et al.. Medicine Bulletin, 2025-08-04
Topic: Brain proteins, microglia and lab models
Plain-language summary
ABSTRACT Background To evaluate the associations of systemic diseases with AMD incidence and explore whether polygenic risk score (PRS) for AMD influences these associations. To assess the impacts of polymorbidities and serum biomarkers on AMD risk. Methods This prospective study of 471156 AMD‐free UK Biobank participants assessed systemic diseases (hypertension, diabetes, cardiovascular disease [CVD], dyslipidemia, chronic kidney disease [CKD], and dementia) and AMD incidence using multivariable Cox proportional hazard models. Results Five systemic diseases were associated with an increased risk of AMD incidence, including hypertension (fully adjusted HR = 1.13, 95% CI: 1.09–1.18; false discovery rate [FDR]‐corrected p = 3.41 × 10 −8 ), diabetes (HR = 1.48, 95% CI: 1.38–1.58; p = 3.79 × 10 −27 ), CVD (HR = 1.13, 95% CI: 1.08–1.18; p = 7.60 × 10 −8 ), dyslipidemia (HR = 1.11, 95% CI: 1.05–1.16; p = 1.28 × 10 −4 ), and CKD (HR = 1.22, 95% CI: 1.07–1.39; p = 0.006), whereas dementia showed no association ( p = 0.74). AMD PRS modified the association with diabetes, but not with the other diseases. The risk of AMD incidence increased in participants with one to five comorbidities ( p for trends < 0.001), compared to those without. Serum biomarkers related to lipid regulation, inflammation, glycemic control, renal function, and nutrition were associated with AMD incidence. Conclusions Major systemic diseases elevate AMD risk, compounded by comorbidities. Serum biomarkers further implicate systemic health in AMD. Holistic health management and regular ocular screenings are crucial for AMD patients and those with systemic diseases.
What this study adds
Evidence grade: Low
This study found that several systemic diseases were associated with increased risk of age-related macular degeneration, but dementia showed no association. Reported effect size: HR = 1.13; HR = 1.48; HR = 1.11.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yu, J., Zhang, Y., Ho, M. T., Kam, K. W., Rong, S. S., Young, A. L., et al. (2025). Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study. Medicine Bulletin. https://doi.org/10.1002/mdb2.70008
Vancouver
Yu J, Zhang Y, Ho MT, Kam KW, Rong SS, Young AL, et al. Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study. Medicine Bulletin. 2025. doi:10.1002/mdb2.70008.
BibTeX
@article{yu2025-f0768c81,
author = {Yu, Jun and Zhang, Yuzhou and Ho, Mary T. and Kam, Ka Wai and Rong, Shi Song and Young, Alvin Lerrmann and Pang, Chi Pui and Tham, Clement Chee Yung and others},
title = {{Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study}},
journal = {Medicine Bulletin},
year = {2025},
doi = {10.1002/mdb2.70008},
url = {https://doi.org/10.1002/mdb2.70008}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results Five systemic diseases were associated with an increased risk of AMD incidence, including hypertension (fully adjusted HR = 1.13, 95% CI: 1.09–1.18; false discovery rate [FDR]‐corrected p = 3.41 × 10 −8 ), diabetes (HR = 1.48, 95% CI: 1.38–1.58; p = 3.79 × 10 −27 ), CVD (HR = 1.13, 95% CI: 1.08–1.18; p = 7.60 × 10 −8 ), dyslipidemia (HR = 1.11, 95% CI: 1.05–1.16; p = 1.28 × 10 −4 ), and CKD (HR = 1.22, 95% CI: 1.07–1.39; p = 0.006), whereas dementia showed no association ( p = 0.74).
- The risk of AMD incidence increased in participants with one to five comorbidities ( p for trends < 0.001), compared to those without.
- Serum biomarkers related to lipid regulation, inflammation, glycemic control, renal function, and nutrition were associated with AMD incidence.
Why it matters
This study found that several systemic diseases were associated with increased risk of age-related macular degeneration, but dementia showed no association. It does not provide information about treating, curing, or preventing Alzheimer's disease.
Study details
- Effect sizeHR = 1.13; HR = 1.48; HR = 1.11
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Medicine Bulletin) |
| Journal's citation record | 0 / 4 | Medicine Bulletin: journal h-index 8 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Li Jia Chen: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 3 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Long-term cohort studies from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.